连续血糖监测对2型糖尿病足患者血糖控制的影响:试点研究
Radhakrishnan Srinivasan1, Aakansha Sinha1, Nikolaos Tentolouris2
1Department of Diabetes and Endocrinology, Tameside and Glossop Integrated Care NHS Foundation Trust, Ashton under Lyne, UK.
The international journal of lower extremity wounds
|August 20, 2025
概括
持续血糖监测 (CGM) 显著改善了2型糖尿病患者的血糖控制和伤口愈合. 这项技术对治疗复杂的糖尿病脚病具有前景.
科学领域:
- 内分泌学
- 糖尿病学
- 伤口护理
背景情况:
- 糖尿病足是2型糖尿病的重要并发症,通常与血糖控制不佳有关.
- 目前的指导方针并不特别建议对T2DM患者进行持续血糖监测.
研究的目的:
- 评估CGM对2型糖尿病患者的血糖控制 (HbA1c) 和伤口愈合的影响.
- 评估将CGM纳入高风险糖尿病足病的可行性和有效性.
主要方法:
- 一项回顾性研究,涉及22名患有糖尿病足的糖尿病患者,他们接受了CGM (Freestyle Libre 2).
- 定期去诊所检查血糖和伤口状况.
- 在基线和CGM使用3个月后进行了HbA1c和伤口大小测量.
主要成果:
- 在CGM使用三个月后,平均HbA1c从84. 10mmol/ mol显著降低到65. 05mmol/ mol (p=0. 0011).
- 平均伤口大小从1. 53厘米2下降到0. 42厘米 (p<0. 001),其中3名患者完全愈合.
- 在基线HbA1c水平较高的患者中,血糖控制得到了最大的改善.
结论:
- 在T2DM患者中,使用CGM可显著改善血糖控制,并对伤口愈合产生积极影响.
- 这些发现表明CGM可能是治疗复杂糖尿病足的有价值的工具,需要进一步研究.
- 需要进行更大规模的研究来验证这些结果,并确认对伤口愈合的长期影响.
相关概念视频
Diabetes: Management and Pharmacotherapy
354
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Peripheral Artery Disease IV: Nursing Management
42
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
42
Diabetes: Symptoms, Diagnosis, and Complications
684
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
684
Hypoglycemia and Glucagon
334
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
334


